Bangkok: Thai researchers have successfully produced an antidote for botulinum toxin, a poison found in canned bamboo shoots. The government announced this development as a significant advancement for pharmaceutical security in the country, reducing the cost of the antidote from 250,000 baht to 25,000 baht per dose. This achievement is set to position Thailand as a potential hub for antidotes in the ASEAN region.

According to Thai News Agency, Ms. Ploytalay Laksmisangchan, Deputy Spokesperson for the Prime Minister's Office, disclosed that the Food and Drug Administration (FDA) of the Ministry of Public Health has registered the TRCS BOTULINUM ANTITOXIN. This modern medicine formulation serves as an antidote to the botulinum toxin associated with consuming canned bamboo shoots. Historically, Thailand imported this antidote due to the lack of domestic production. The new development marks a significant step in enhancing the country's drug security, substantially cutting costs from the previous import expense of approximately 250,000 baht to a new cost of around 25,000 baht.

Ms. Ploytalee highlighted that the success results from the collaborative efforts of multiple organizations, including the Thai Red Cross Society, the Queen Saovabha Memorial Institute, the Biotechnology Institute, the National Vaccine Institute, the Government Pharmaceutical Organization (GPO), and the National Health Security Office (NHSO). These organizations have worked together to integrate the antidote into the benefits system for Thai citizens. This development showcases Thailand's ability to transform research into practical solutions and exemplifies the interconnected collaboration across various sectors, including research, innovation, manufacturing, regulatory bodies, and public benefit units.

The TRCS Botulinum Antitoxin is produced on a non-profit basis to ensure national pharmaceutical security and provides a reliable resource. While botulism is rare, its severity can lead to muscle weakness and respiratory failure, making the antitoxin crucial for patient survival in emergencies or cases of biological sabotage. By producing its own antitoxin, Thailand ensures rapid access to treatment for domestic patients and strengthens its pharmaceutical security. This achievement not only guarantees equitable access to life-saving medicine for Thai patients but also elevates Thailand's status as a regional pharmaceutical security hub, ready to collaborate with neighboring countries to bolster public health security.